Stock Events

Stock Events

Stoke Therapeutics (STOK) Q2 2026 Earnings

7MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.81

0.09

1

1.9

Details

Expected EPS

-0.8075

Actual EPS

-0.79

Surprise EPS

0.02

Surprise Percent

+2.17%

Description

Stoke Therapeutics (STOK) has reported earnings of -0.79 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.